All content for Chat Lounge is the property of China Plus and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A place to unpack reactions to major events and hot issues in a casual setting.
Why foreign firms are betting big on China's biopharma future
Chat Lounge
55 minutes
5 months ago
Why foreign firms are betting big on China's biopharma future
China's biopharma boom is on, and foreign investors are flooding in. As we dive into the billion-dollar wave of foreign investment reshaping China's biotech landscape, check out Why pharma giants like Roche and AstraZeneca are expanding their footprint here. What strategic edge does China offer in global drug development? And can the country become a global biopharma innovation powerhouse by 2030?
Host Tu Yun joins Dr. Zhou Mi, the Deputy Director of the Institute of American and Oceania Study, Chinese Academy of International Trade and Economic Cooperation,
Chat Lounge
A place to unpack reactions to major events and hot issues in a casual setting.
